News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
492,210 Results
Type
Article (28549)
Company Profile (74)
Press Release (463587)
Section
Business (145939)
Career Advice (813)
Deals (24773)
Drug Delivery (53)
Drug Development (55105)
Employer Resources (67)
FDA (13197)
Job Trends (10468)
News (244273)
Policy (22827)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1847)
Accelerated approval (1)
Adcomms (9)
Allergies (71)
Alliances (33667)
ALS (56)
Alzheimer's disease (884)
Antibody-drug conjugate (ADC) (47)
Approvals (13251)
Artificial intelligence (170)
Autoimmune disease (9)
Automation (6)
Bankruptcy (209)
Best Places to Work (8319)
BIOSECURE Act (5)
Biosimilars (41)
Biotechnology (57)
Bladder cancer (48)
Brain cancer (18)
Breast cancer (184)
Cancer (1421)
Cardiovascular disease (113)
Career advice (712)
Career pathing (14)
CAR-T (82)
Cell therapy (242)
Cervical cancer (14)
Clinical research (46232)
Collaboration (477)
Compensation (226)
Complete response letters (9)
COVID-19 (1602)
CRISPR (12)
C-suite (158)
Cystic fibrosis (49)
Data (1513)
Decentralized trials (2)
Denatured (16)
Depression (28)
Diabetes (179)
Diagnostics (4511)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (21)
Drug discovery (58)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (54)
Earnings (59369)
Editorial (18)
Employer branding (11)
Employer resources (65)
Events (74154)
Executive appointments (528)
FDA (14134)
Featured Employer (19)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (460)
Gene editing (39)
Generative AI (12)
Gene therapy (145)
GLP-1 (439)
Government (3154)
Grass and pollen (3)
Guidances (37)
Healthcare (14444)
Huntington's disease (10)
IgA nephropathy (14)
Immunology and inflammation (43)
Indications (21)
Infectious disease (1670)
Inflammatory bowel disease (87)
Inflation Reduction Act (5)
Influenza (23)
Intellectual property (54)
Interviews (84)
IPO (11447)
IRA (20)
Job creations (2481)
Job search strategy (656)
Kidney cancer (7)
Labor market (10)
Layoffs (226)
Leadership (7)
Legal (4937)
Liver cancer (56)
Lung cancer (221)
Lymphoma (97)
Machine learning (2)
Management (23)
Manufacturing (122)
MASH (50)
Medical device (13224)
Medtech (13228)
Mergers & acquisitions (13669)
Metabolic disorders (436)
Multiple sclerosis (51)
NASH (12)
Neurodegenerative disease (46)
Neuropsychiatric disorders (10)
Neuroscience (1205)
NextGen: Class of 2025 (4677)
Non-profit (3172)
Northern California (1670)
Now hiring (16)
Obesity (223)
Opinion (91)
Ovarian cancer (55)
Pain (60)
Pancreatic cancer (53)
Parkinson's disease (89)
Partnered (14)
Patents (105)
Patient recruitment (76)
Peanut (39)
People (45512)
Pharmaceutical (21)
Pharmacy benefit managers (11)
Phase I (13536)
Phase II (20128)
Phase III (16155)
Pipeline (798)
Podcasts (24)
Policy (51)
Postmarket research (1886)
Preclinical (4656)
Press Release (68)
Prostate cancer (72)
Psychedelics (19)
Radiopharmaceuticals (187)
Rare diseases (199)
Real estate (3909)
Recruiting (22)
Regulatory (16199)
Reports (19)
Research institute (1721)
Resumes & cover letters (104)
Rett syndrome (3)
RNA editing (2)
RSV (18)
Schizophrenia (51)
Series A (71)
Series B (53)
Service/supplier (3)
Sickle cell disease (22)
Southern California (1421)
Special edition (4)
Spinal muscular atrophy (111)
Sponsored (15)
Startups (2500)
Stomach cancer (9)
Supply chain (38)
The Weekly (8)
United States (14966)
Vaccines (358)
Venture capitalists (14)
Webinars (9)
Weight loss (142)
Women's health (16)
Worklife (4)
Date
Today (102)
Last 7 days (543)
Last 30 days (2005)
Last 365 days (23798)
2025 (5672)
2024 (25108)
2023 (29138)
2022 (38629)
2021 (41594)
2020 (40397)
2019 (34389)
2018 (26300)
2017 (23634)
2016 (22615)
2015 (27196)
2014 (20976)
2013 (17425)
2012 (18752)
2011 (19342)
2010 (18207)
Location
Africa (468)
Alabama (23)
Alaska (4)
Arizona (130)
Arkansas (10)
Asia (29182)
Australia (4531)
California (3714)
Canada (1381)
China (362)
Colorado (175)
Connecticut (184)
Delaware (107)
Europe (59862)
Florida (599)
Georgia (131)
Idaho (44)
Illinois (386)
India (16)
Indiana (230)
Iowa (3)
Japan (128)
Kansas (78)
Kentucky (20)
Louisiana (6)
Maine (62)
Maryland (675)
Massachusetts (2732)
Michigan (149)
Minnesota (322)
Mississippi (2)
Missouri (62)
Montana (27)
Nebraska (22)
Nevada (42)
New Hampshire (60)
New Jersey (1244)
New Mexico (13)
New York (1101)
North Carolina (695)
North Dakota (5)
Northern California (1670)
Ohio (137)
Oklahoma (8)
Oregon (23)
Pennsylvania (910)
Puerto Rico (7)
Rhode Island (23)
South America (695)
South Carolina (17)
Southern California (1421)
Tennessee (77)
Texas (583)
Utah (131)
Virginia (96)
Washington D.C. (39)
Washington State (285)
West Virginia (3)
Wisconsin (44)
492,210 Results for "apyx medical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
March 13, 2025
·
18 min read
Press Releases
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025
February 27, 2025
·
1 min read
Press Releases
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results
January 14, 2025
·
5 min read
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit.
April 11, 2024
·
3 min read
Press Releases
Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
·
1 min read
Press Releases
Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™
January 6, 2025
·
4 min read
Press Releases
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
November 13, 2024
·
1 min read
Business
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Apyx Medical Corporation today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
April 25, 2024
·
2 min read
Business
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
Apyx Medical Corporation today reported financial results for its first quarter ended March 31, 2024; and reaffirmed its financial expectations for the full year ending December 31, 2024.
May 9, 2024
·
13 min read
Business
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the fourth quarter and fiscal year 2023 will be released before the market opens on Thursday, March 21st.
March 4, 2024
·
1 min read
1 of 49,221
Next
